Thoracic small round cell sarcoma with FGFR2::DCTN2 fusion.

Autor: Nakamura H; Laboratory of Genomic Pathology, Osaka International Cancer Institute, Osaka, Japan.; Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan., Kukita Y; Laboratory of Genomic Pathology, Osaka International Cancer Institute, Osaka, Japan., Tamiya H; Department of Orthopaedics, Osaka International Cancer Institute, Osaka, Japan., Takenaka S; Department of Orthopaedics, Osaka International Cancer Institute, Osaka, Japan., Yagi T; Department of Outpatient Chemotherapy, Osaka International Cancer Institute, Osaka, Japan.

Publikováno v: Histopathology [Histopathology] 2024 Oct; Vol. 85 (4), pp. 693-695. Date of Electronic Publication: 2024 Jun 11.

Recurrent GATA3 P409Afs*99 Frameshift Extension Mutations in Sweat-gland Carcinoma With Neuroendocrine Differentiation.

Autor: Goto K; Department of Diagnostic Pathology and Cytology.; Department of Diagnostic Pathology, Osaka National Hospital, Osaka.; Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto.; Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital.; Department of Pathology, Itabashi Central Clinical Laboratory.; Department of Anatomic Pathology, Tokyo Medical University, Tokyo.; Department of Dermatology, Hyogo Cancer Center, Akashi.; Department of Diagnostic Pathology, Chutoen General Medical Center, Kakegawa.; Department of Dermato-Oncology/Dermatology, National Hospital Organization Kagoshima Medical Center, Kagoshima., Kiniwa Y; Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan., Kukita Y; Laboratory of Genomic Pathology, Research Center., Ohe S; Department of Dermatologic Oncology, Osaka International Cancer Institute., Hiraki T; Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto., Hishima T; Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital., Takai T; Department of Dermatology, Hyogo Cancer Center, Akashi., Honma K; Department of Diagnostic Pathology and Cytology.

Publikováno v: The American journal of surgical pathology [Am J Surg Pathol] 2024 May 01; Vol. 48 (5), pp. 528-537. Date of Electronic Publication: 2024 Feb 14.

Primary Cutaneous NUT Carcinoma: Clinicopathologic and Genetic Study of 4 Cases.

Autor: Goto K; Department of Diagnostic Pathology and Cytology.; Laboratory of Genomic Pathology, Research Center, Osaka International Cancer Institute.; Department of Diagnostic Pathology, Osaka National Hospital, Osaka.; Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital.; Department of Pathology, Itabashi Central Clinical Laboratory.; Department of Anatomic Pathology, Tokyo Medical University, Tokyo.; Department of Dermato-Oncology/Dermatology, National Hospital Organization Kagoshima Medical Center, Kagoshima.; Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto.; Department of Diagnostic Pathology, Chutoen General Medical Center, Kakegawa., Kukita Y; Department of Dermatology, Hyogo Cancer Center, Akashi., Hishima T; Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital., Matsushita S; Department of Dermato-Oncology/Dermatology, National Hospital Organization Kagoshima Medical Center, Kagoshima., Tsuyuki T; Department of Diagnostic Pathology, Kainan Hospital, Yatomi., Makihara K; Department of Surgical Pathology, Kyushu Rosai Hospital, Kitakyushu., Koga K; Department of Pathology, Fukuoka University Hospital, Fukuoka., Mukumoto S; COSMOS Clinic, Yukuhashi, Japan., Honma K; Department of Diagnostic Pathology and Cytology.

Publikováno v: The American journal of surgical pathology [Am J Surg Pathol] 2024 Aug 01; Vol. 48 (8), pp. 942-952. Date of Electronic Publication: 2024 May 06.

Rcn1, the fission yeast homolog of human DSCR1, regulates arsenite tolerance independently from calcineurin.

Autor: Takasaki T; Laboratory of Molecular Pharmacogenomics, Department of Pharmaceutical Sciences, Kindai University, Osaka, Japan., Bamba A; Laboratory of Molecular Pharmacogenomics, Department of Pharmaceutical Sciences, Kindai University, Osaka, Japan., Kukita Y; Laboratory of Molecular Pharmacogenomics, Department of Pharmaceutical Sciences, Kindai University, Osaka, Japan., Nishida A; Laboratory of Molecular Pharmacogenomics, Department of Pharmaceutical Sciences, Kindai University, Osaka, Japan., Kanbayashi D; Laboratory of Molecular Pharmacogenomics, Department of Pharmaceutical Sciences, Kindai University, Osaka, Japan., Hagihara K; Laboratory of Molecular Pharmacogenomics, Department of Pharmaceutical Sciences, Kindai University, Osaka, Japan.; Laboratory of Hygienic Science, Department of Pharmacy, School of Pharmacy, Hyogo Medical University, Kobe, Japan., Satoh R; Laboratory of Molecular Pharmacogenomics, Department of Pharmaceutical Sciences, Kindai University, Osaka, Japan., Ishihara K; Laboratory of Pathological Biochemistry, Kyoto Pharmaceutical University, Kyoto, Japan., Sugiura R; Laboratory of Molecular Pharmacogenomics, Department of Pharmaceutical Sciences, Kindai University, Osaka, Japan.

Publikováno v: Genes to cells : devoted to molecular & cellular mechanisms [Genes Cells] 2024 Jul; Vol. 29 (7), pp. 589-598. Date of Electronic Publication: 2024 May 07.

Clonal Origin and Lineage Ambiguity in Mixed Neuroendocrine Carcinoma of the Uterine Cervix.

Autor: Masuda M; Department of Clinical Bio-resource Research and Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Japan., Iida K; Laboratory of Cell Systems, Institute for Protein Research, Osaka University, Osaka, Japan., Iwabuchi S; Department of Molecular Pathophysiology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan., Tanaka M; Department of Clinical Bio-resource Research and Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Japan., Kubota S; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Japan; Department of Biochemistry, Osaka International Cancer Institute, Osaka, Japan., Uematsu H; Department of Clinical Bio-resource Research and Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Onuma K; Department of Clinical Bio-resource Research and Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Kukita Y; Department of Molecular and Medical Genetics, Osaka International Cancer Institute, Osaka, Japan., Kato K; Department of Molecular and Medical Genetics, Osaka International Cancer Institute, Osaka, Japan., Kamiura S; Department of Gynecology, Osaka International Cancer Institute, Osaka, Japan., Nakajima A; Department of Biochemistry, Osaka International Cancer Institute, Osaka, Japan; Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Coppo R; Department of Clinical Bio-resource Research and Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Kanda M; Department of Clinical Bio-resource Research and Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Japan., Yoshino K; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Japan., Ueda Y; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Japan., Morii E; Department of Pathology, Osaka University Graduate School of Medicine, Suita, Japan., Kimura T; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Japan., Kondo J; Department of Clinical Bio-resource Research and Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Biochemistry, Osaka International Cancer Institute, Osaka, Japan., Okada-Hatakeyama M; Laboratory of Cell Systems, Institute for Protein Research, Osaka University, Osaka, Japan., Hashimoto S; Department of Molecular Pathophysiology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan., Inoue M; Department of Clinical Bio-resource Research and Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Biochemistry, Osaka International Cancer Institute, Osaka, Japan. Electronic address: masa_inoue@kuhp.kyoto-u.ac.jp.

Publikováno v: The American journal of pathology [Am J Pathol] 2024 Mar; Vol. 194 (3), pp. 415-429. Date of Electronic Publication: 2023 Dec 14.